SPP1 and multiple sclerosis: A microglia population expressing Spp1 has been described in the axon tracts of the pre-myelinated brain during early post-natal development in mouse (Hammond et al., 2019) and has also been associated with a specific microglia population from a model of toxic demyelination and in human microglia of multiple sclerosis patients (Masuda et al., 2019).